An experimental immune-system therapy can often lead to complete remission in advanced acute lymphoblastic leukemia (ALL) patients who have run out of other options.
Amgen announced that the Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for blinatumomab
NKT Therapeutics announced that the Food and Drug Administration (FDA) has granted Fast Track designation to NKTT120 for the treatment of sickle cell disease.
For patients in the intensive care unit (ICU) with septic shock, outcomes are similar for those who receive blood transfusion at a higher or lower hemoglobin threshold.
Blood group AB and higher factor VIII are associated with increased incidence of cognitive impairment.
Millennium: The Takeda Oncology Company announced that the Food and Drug Administration (FDA) has approved Velcade (bortezomib) for the treatment of mantle cell lymphoma (MCL) in previously untreated patients.version of Eisai's Dacogen.
Physicians at the Detroit Medical Center have been awarded a unique prize for an unconventional treatment – using bacon to stop an uncontrollable nosebleed in a 4-year-old with Glanzmann thrombasthenia.